Validation of the histologic grading for ovarian clear cell adenocarcinoma: A retrospective multi-institutional study by the Japan clear cell carcinoma study group

International Journal of Gynecological Pathology

Volumn 30, Issue 2, 2011, Pages 129-138

  Yamamoto, Sohei ^a   Kasajima, Atsuko ^c   Takano, Masashi ^a   Yaegashi, Nobuo ^c   Fujiwara, Hiroyuki ^d   Kuzuya, Kazuo ^e,j   Kigawa, Junzo ^f   Tsuda, Hiroshi ^a,k,l   Kurachi, Hirohisa ^h   Kikuchi, Yoshihiro ^b   Sugiyama, Toru ⁱ   Tsuda, Hitoshi ^g   Moriya, Takuya ^c,m  

^a Ohki Memorial Kikuchi Cancer Clinic for Women   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f TOTTORI UNIVERSITY HOSPITAL   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

^h YAMAGATA UNIVERSITY   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j Kuzuya Clinic   (Japan)

^k KEIO UNIVERSITY   (Japan)

^l NATIONAL CANCER CENTER HOSPITAL   (Japan)

^m KAWASAKI MEDICAL SCHOOL   (Japan)

more..

Author keywords

Clear cell adenocarcinoma; Grading; Ovarian cancer; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CLEAR CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; TREATMENT RESPONSE;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; JAPAN; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 79951767769     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181f71264     Document Type: Article

References (28)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2001:791-904.
2. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9. (Pubitemid 30331967)
3. Ikeda K, Sakai K, Yamamoto R, et al. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer 2003;13:776-84. (Pubitemid 38235222)
4. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:218-28.
5. Kaku T, Ogawa S, Kawano Y, et al. Histological classification of ovarian cancer. Med Electron Microsc 2003;36:9-17. (Pubitemid 36504385)
6. Gynecologic cancer comittee, Japan society of obstetrics and gynecology. Annual report of gynecological cancer patients in Japan 2006 [in Japanese]. Acta Obstetrica et Gynecologica Japonica 2008; 60: 1001-85.
7. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008;109:370-6.
8. Mizuno M, Kikkawa F, Shibata K, et al. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J Surg Oncol 2006;94:138-43. (Pubitemid 44267195)
9. O'Brien ME, Schofield JB, Tan S, et al. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 1993;49:250-4. (Pubitemid 23170001)
10. TakanoM,Kikuchi Y, Yaegashi N, et al.Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006;94:1369-74. (Pubitemid 43772268)
11. Kennedy AW, Biscotti CV, Hart WR, et al. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50:334-8. (Pubitemid 23299729)
12. Montag AG, Jenison EL, Griffiths CT, et al. Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 1989;8:85-96. (Pubitemid 19116244)
13. Imachi M, Tsukamoto N, Shimamoto T, et al. Clear cell carcinoma of the ovary: a clinicopathologic analysis of 34 cases. Int J Gynecol Cancer 1991;1:113-9.
14. Auer G, Einhorn N, Nilsson B, et al. Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol 1996;35:93-8.
15. Fischer-Colbrie J, Witt A, Heinzl H, et al. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 1997; 17:613-9. (Pubitemid 27105536)
16. Miller BE, Lavia LA, Horbelt DV. The prognostic value of image analysis in ovarian cancer. Cancer 1991;67:1318-21.
17. Brinkhuis M, Meijer GA, van Diest PJ, et al. Minimum spanning tree analysis in advanced ovarian carcinoma. An investigation of sampling methods, reproducibility and correlation with histologic grade. Anal Quant Cytol Histol 1997;19: 194-201.
18. Haapasalo H, Collan Y, SeppäA, et al. Prognostic value of ovarian carcinoma grading methods: a method comparison study. Histopathology 1990;16:1-7. (Pubitemid 20123329)
19. Geppert M, Smyczek-Gargya B. Morphologic criteria for the prognosis of serous cystadenocarcinoma of the ovary. Gynecol Obstet Invest 1995;39:136-40.
20. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
21. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998;82:893-901. (Pubitemid 28104169)
22. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
23. Frierson HF Jr, Wolber RA, Berean KW, et al. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 1995;103:195-8.
24. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features-problems involved in the architectural grading system. Gynecol Oncol 1998;70:2-12. (Pubitemid 28368866)
25. Mayr D, Diebold J. Grading of ovarian carcinomas. Int J Gynecol Pathol 2000;19:348-53.
26. Ryu SY, Park SI, Nam BH, et al. Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective of Korean Gynecologic Oncology Group. Ann Oncol 2009;20:1032-6.
27. Itamochi H, Kigawa J, Sugiyama T, et al. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol 2002;100:281-7. (Pubitemid 34874791)
28. Crozier MA, Copeland LJ, Silva EG, et al. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 1989;35:199-203. (Pubitemid 19268557)